Castle Hook Partners’s Eli Lilly LLY Stock Holding History

Castle Hook Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,051,200	Closed	-$1.6B	–	83
2025 Q2	$1.6B	Buy	+2,051,200	New	+$1.59B	9.09%	3

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Castle Hook Partners's LLY Position: Q1 2026 in Review

Castle Hook Partners sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 383,550 shares — an estimated $412M sold.

Castle Hook Partners first reported a position in LLY in Q4 2024 and held it in 5 quarters. The position peaked at $412M in Q4 2025. 4,351 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Castle Hook Partners reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
Castle Hook Partners sold 383,550 Eli Lilly shares in Q1 2026, an estimated $412M.
Castle Hook Partners first reported a position in Eli Lilly in Q4 2024 and held it in 5 quarters.
Castle Hook Partners's Eli Lilly position peaked at $412M in Q4 2025.
4,351 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Castle Hook Partners's 13F filing for Q1 2026, filed 15 May 2026.